This inventor holds 1 USPTO granted patent. Top assignee: Viiv Healthcare UK (No. 4) Limited. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Maxime Soumeillant: Innovator in HIV Research
Introduction
Maxime Soumeillant is a notable inventor based in New Brunswick, NJ (US). He has made significant contributions to the field of HIV research, particularly through his innovative methods for producing HIV maturation inhibitors. His work is crucial in the ongoing fight against HIV/AIDS.
Latest Patents
Maxime holds one patent titled "Methods of producing an HIV maturation inhibitor." This patent outlines a method for producing an HIV maturation inhibitor compound using betulin as the starting material, employing Lossen rearrangement techniques. This innovative approach has the potential to enhance the effectiveness of treatments for HIV.
Career Highlights
Maxime is currently employed at ViiV Healthcare UK (No. 4) Limited, where he continues to advance his research in HIV treatment. His work at ViiV Healthcare is instrumental in developing new therapeutic strategies to combat HIV.
Collaborations
Maxime collaborates with talented professionals in his field, including Adrian Ortiz and Scott A. Savage. These collaborations foster a dynamic environment for innovation and research.
Conclusion
Maxime Soumeillant's contributions to HIV research through his innovative patent and work at ViiV Healthcare highlight his commitment to improving health outcomes for individuals affected by HIV. His efforts exemplify the importance of innovation in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile